UNICANCER: all 219 studies
Page 2 of 3. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- Nivolumab in Recurrent and/or Metastatic SCCHNCompletedNCT03226756Phase 2
- QUALIOR Feasibility and Efficacy of a Supervised Home-based Standard Physical Exercise ProgramActive, not recruitingNCT03169075Not applicable
- Improving SUrgery of Liver Metastases: a Trial of the Arterial Chemotherapy NetworkCompletedNCT03164655Phase 2
- Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only MetastasesActive, not recruitingNCT03143322Not applicable
- Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and NeckCompletedNCT03132038Phase 2
- Hypofractionated vs Standard Radiotherapy in Breast Cancer With an Indication for Regional Lymph Node Irradiation About Lymphedema OccurrenceActive, not recruitingNCT03127995Not applicable
- Treatment of Metastatic Castrate Resistant Prostate Cancer Patients According to Circulating Tumor Cells KineticCompletedNCT03101046Phase 2
- Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast CancerWithdrawnNCT03080428Not applicable
- PAlbociclib and Circulating Tumor DNA for ESR1 Mutation DetectionCompletedNCT03079011Phase 3
- Tracking Triple-negative Breast Cancer Evolution Through TherapyActive, not recruitingNCT03077776Not applicable
- Nivolumab in Patients With Metastatic Renal Cell Carcinoma Who Have Progresses During or After Prior Systemic Anti-angiogenic RegimenCompletedNCT03013335Phase 2
- Secured Access to Pembrolizumab for Patients With Selected Rare Cancer TypesCompletedNCT03012620Phase 2
- Secured Access to Nivolumab for Adult Patients With Selected Rare Cancer TypesCompletedNCT03012581Phase 2
- Durvalumab and Endocrine Therapy in ER+/Her2- Breast Cancer After CD8+ Infiltration Effective Immune-Attractant ExposureCompletedNCT02997995Phase 2
- Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer PatientsCompletedNCT02980510Phase 2
- IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant SettingCompletedNCT02967289Phase 3
- Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN LossTerminatedNCT02822482Phase 1/2
- I-MVAC +/- Panitumumab as First-line Treatment of Advanced Urothelial Carcinoma Without H-Ras Nor K-Ras MutationsCompletedNCT02818725Phase 3
- Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the PenisActive, not recruitingNCT02817958Phase 2
- Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast CancerCompletedNCT02773004Not applicable
- Phase I Evaluating the Combination of Ribociclib+Capecitabine in Locally Advanced/Metastatic Breast Cancer HER2 NegativeCompletedNCT02754011Phase 1
- EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted TherapiesCompletedNCT02701907Not applicable
- Neoadjuvant Treatment for Advanced Rectal CarcinomaCompletedNCT02551237Phase 3
- A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic CarcinomaCompletedNCT02539537Phase 3
- A Study to Assess the Efficacy of Rucaparib in Metastatic Breast Cancer Patients With a BRCAness Genomic SignatureCompletedNCT02505048Phase 2
- Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR InhibitorCompletedNCT02444390Not applicable
- Treatment After Irinotecan-based Frontline Therapy: Maintenance With Erbitux (in Patients wtRAS mCRC)CompletedNCT02404935Phase 2
- Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal WomenCompletedNCT02400567Phase 2
- Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland CarcinomaCompletedNCT02393820Phase 2
- A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone SarcomasCompletedNCT02389244Phase 2
- Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)CompletedNCT02363751Phase 2
- Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A StatusCompletedNCT02339532Phase 2
- Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast CancerCompletedNCT02324088Phase 3
- Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic AlterationsActive, not recruitingNCT02304809Phase 2
- SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerActive, not recruitingNCT02299999Phase 2
- SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC PatientsCompletedNCT02117167Phase 2
- Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1CompletedNCT02034981Phase 2
- Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After ProstatectomyActive, not recruitingNCT01994239Phase 2
- A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerActive, not recruitingNCT01957436Phase 3
- A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of RelapseActive, not recruitingNCT01952223Phase 3
- Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal CancerCompletedNCT01919879Phase 2
- Abiraterone Acetate in Molecular Apocrine Breast CancerCompletedNCT01842321Phase 2
- Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone TherapyActive, not recruitingNCT01805271Phase 3
- Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal CancerCompletedNCT01804790Phase 3
- Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following SurgeryCompletedNCT01780220Phase 1/2
- Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast CancerCompletedNCT01745757
- A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and TaxanesCompletedNCT01620242Phase 2
- Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine TreatmentCompletedNCT01564056Phase 3
- Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic AdenocarcinomaCompletedNCT01526135Phase 3
- MEGA (Met or EGFR Inhibition in Gastroesophageal Adenocarcinoma): FOLFOX Alone or in Combination With AMG 102 or Panitumumab as First-line Treatment in Patients With Advanced Gastroesophageal AdenocarcinomaCompletedNCT01443065Phase 2
- Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic MetastasesCompletedNCT01442935Phase 2
- Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed UterineCompletedNCT01442662Phase 2
- Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With BevacizumabCompletedNCT01442649Phase 2
- Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients.Active, not recruitingNCT01442246Phase 3
- Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC PatientsCompletedNCT01415674Phase 2
- High Throughput Technologies to Drive Breast Cancer Patients to Specific Phase I/II Trials of Targeted AgentsCompletedNCT01414933
- Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer TreatmentActive, not recruitingNCT01376752Phase 3
- Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical CancerTerminatedNCT01363466Phase 3
- Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by SurgeryCompletedNCT01313377Phase 3
- Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer.CompletedNCT01262469Phase 2
- Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly PatientsCompletedNCT01254513Phase 2
- Standard or Hypofractionated Radiotherapy Versus Accelerated Partial Breast Irradiation (APBI) for Breast CancerActive, not recruitingNCT01247233Not applicable
- Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid TumorsCompletedNCT01165385Phase 1
- Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18)Active, not recruitingNCT00967863Not applicable
- Lapatinib Ditosylate and Capecitabine in Treating Patients With Stage IV Breast Cancer and Brain MetastasesCompletedNCT00967031Phase 2
- Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal CancerTerminatedNCT00955240Phase 2
- Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerCompletedNCT00861094Phase 2/3
- Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer PatientsCompletedNCT00820547Phase 2
- Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerCompletedNCT00769405Phase 3
- Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By SurgeryTerminatedNCT00674414Phase 2
- Letrozole in Preventing Breast Cancer in Postmenopausal Women With a BRCA1 or BRCA2 MutationCompletedNCT00673335Phase 3
- Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate CancerCompletedNCT00667069Phase 3
- Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast CancerCompletedNCT00629616Phase 2
- Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by SurgeryTerminatedNCT00541112Phase 2
- Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell CancerCompletedNCT00541008Phase 2
- Positron Emission Tomography Using 3'-Deoxy-3'-(18F) Fluorothymidine in Treating Women With Locally Advanced Cancer in One Breast Who Are Receiving ChemotherapyCompletedNCT00534274Not applicable
- Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast CancerCompletedNCT00513058Phase 1
- Combined Chemotherapy With or Without Zoledronic Acid for Patients With OsteosarcomaActive, not recruitingNCT00470223Phase 3
- Doxorubicin and Cyclophosphamide in Treating Older Women With Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By SurgeryCompletedNCT00424203Phase 2
- Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryCompletedNCT00423696Phase 2
- Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerCompletedNCT00423475Phase 3
- Imatinib Mesylate in Treating Patients With Recurrent or Refractory FibromatosisCompletedNCT00287846Phase 1/2
- Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal CancerCompletedNCT00227747Phase 3
- Docetaxel in Treating Older Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT00227708Phase 2
- Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaCompletedNCT00227669Phase 2
- Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By SurgeryCompletedNCT00217607Phase 2
- Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00112697Phase 2
- Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerCompletedNCT00112658Phase 2/3
- Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00104741Phase 3
- Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate CancerCompletedNCT00104715Phase 3
- Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast CancerCompletedNCT00104702Phase 2
- Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT00104689Phase 2
- Docetaxel in Treating Older Women With Metastatic Breast CancerTerminatedNCT00104624Phase 2
- Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal CancerCompletedNCT00066274Phase 2
- Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerCompletedNCT00056095Phase 2
- Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of RelapseCompletedNCT00055731Phase 3
- Combination Chemotherapy in Treating Women With Stage I Breast CancerCompletedNCT00055679Phase 3
- Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCompletedNCT00054587Phase 3
- Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast CancerTerminatedNCT00053911Phase 3
- Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate CancerCompletedNCT00010244Phase 3